Literature DB >> 2954609

Bronchoconstrictor properties of preservatives in ipratropium bromide (Atrovent) nebuliser solution.

C R Beasley, P Rafferty, S T Holgate.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2954609      PMCID: PMC1246359          DOI: 10.1136/bmj.294.6581.1197-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  4 in total

1.  Bronchoconstriction induced by ipratropium bromide in asthma: relation to hypotonicity.

Authors:  J S Mann; P H Howarth; S T Holgate
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-25

2.  Benzalkonium chloride: selective inhibitor of histamine release induced by compound 48/80 and other polyamines.

Authors:  G W Read; E F Kiefer
Journal:  J Pharmacol Exp Ther       Date:  1979-12       Impact factor: 4.030

3.  Importance of calcium in citric acid-induced airway constriction.

Authors:  H Downes; C A Hirshman
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1983-11

4.  Immunoglobulin E decapeptide-induced 5-hydroxytryptamine release from rat peritoneal mast cells. Comparison with corticotropin-(1-24)-peptide, polyarginine, polylysine and antigen.

Authors:  J W Coleman; S T Holgate; M K Church; R C Godfrey
Journal:  Biochem J       Date:  1981-09-15       Impact factor: 3.857

  4 in total
  25 in total

1.  A non-bronchoconstrictor, bacteriostatic preservative for nebuliser solutions.

Authors:  Q A Summers; M R Nesbit; R Levin; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

2.  AB569, a nontoxic chemical tandem that kills major human pathogenic bacteria.

Authors:  Cameron T McDaniel; Warunya Panmanee; Geoffrey L Winsor; Erin Gill; Claire Bertelli; Michael J Schurr; Prateek Dongare; Andrew T Paul; Seung-Hyun B Ko; Gee W Lau; Nupur Dasgupta; Amy L Bogue; William E Miller; Joel E Mortensen; David B Haslam; Phillip Dexheimer; Daniel A Muruve; Bruce J Aronow; Malcolm D E Forbes; Marek Danilczuk; Fiona S L Brinkman; Robert E W Hancock; Thomas J Meyer; Daniel J Hassett
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-18       Impact factor: 11.205

3.  Paradoxical bronchoconstriction in wheezing infants after nebulised preservative free iso-osmolar ipratropium bromide.

Authors:  C O'Callaghan; A D Milner; A Swarbrick
Journal:  BMJ       Date:  1989-12-09

4.  Bacterial contamination of home nebuliser.

Authors:  K L Barnes; R Clifford; S T Holgate; D Murphy; P Comber; E Bell
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-03

Review 5.  Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).

Authors:  L K Golightly; S S Smolinske; M L Bennett; E W Sutherland; B H Rumack
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

6.  Adverse reactions to the non-drug constituents of nebuliser solutions.

Authors:  R Beasley; P Rafferty; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1988-03       Impact factor: 4.335

7.  Sterility and Stability Testing of Preservative-free Albuterol.

Authors:  Savannah L Gulley; Sarah M Baltzley; Alan D Junkins; Tristan D Murray; Stephanie F Simms; Janice E Sullivan; Abeer M Al-Ghananeem; Adrian R O'Hagan
Journal:  J Pediatr Pharmacol Ther       Date:  2019 Jan-Feb

8.  Hypoxaemia after nebulised salbutamol in wheezy infants: the importance of aerosol acidity.

Authors:  J Seidenberg; Y Mir; H von der Hardt
Journal:  Arch Dis Child       Date:  1991-06       Impact factor: 3.791

9.  Development of a multidose formulation for a humanized monoclonal antibody using experimental design techniques.

Authors:  Supriya Gupta; Elizabet Kaisheva
Journal:  AAPS PharmSci       Date:  2003

Review 10.  Anticholinergic agents for chronic asthma in adults.

Authors:  M Westby; M Benson; P Gibson
Journal:  Cochrane Database Syst Rev       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.